Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Utilization of MAsS in Patients Undergoing LT for HCC

Megadott ok: Discontinued by Amra Medical due to funding.

A legfontosabb adatok

Hol
New York (Egyesült Államok)A helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Columbia University Irving Medical CenterNew York, Egyesült ÁllamokNo longer taking part

A vizsgálat adatai

Ki végzi
Columbia University
Azonosító
NCT05184283
A regiszteradat frissítve
2023. december 7.
Eredeti leírás
The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.A teljes eredeti leírásKevesebb

Longitudinal Assessment of Muscle Health in Patients Undergoing Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)

The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.

Bevonási feltételek: Age between 18 and 75 years; Diagnosis of cirrhosis and HCC; Listed or in evaluation for liver transplantation.

Kizáró feltételek: History of prior solid organ transplantation; In evaluation or listed for any other solid organ transplant (other than liver transplant); Contraindication to MR examination; Metastatic HCC.

ClinicalTrials.gov NCT05184283

Építés alatt, nem éles – Utilization of MAsS in Patients Undergoing LT for HCC (NCT05184283) – Frontlight Research